Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Coloplast Danmark A/S
A/S
Active
CVR 19020940
Holtedam 1, 3050
Humlebæk
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1995 · 30 years old
71 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Coloplast Danmark A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
134M
101M
67M
34M
0M
2021: 71M
71M
2021
2022: 89M (+25% vs 2021)
89M
+25%
2022
2023: 103M (+16% vs 2022)
103M
+16%
2023
2024: 97M (-6% vs 2023)
97M
-6%
2024
2025: 108M (+11% vs 2024)
108M
+11%
2025
EBITDA
DKK millions
49M
36M
24M
12M
0M
2021: 18M
18M
2021
2022: 29M (+61% vs 2021)
29M
+61%
2022
2023: 39M (+34% vs 2022)
39M
+34%
2023
2024: 28M (-28% vs 2023)
28M
-28%
2024
2025: 39M (+39% vs 2024)
39M
+39%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
107.809
97.098
102.930
88.520
70.684
Staff expenses
-0
-0
-0
-0
-0
EBITDA
38.579
27.743
38.797
29.200
17.636
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
38.579
27.743
38.797
29.200
17.636
Net financials
1.000
1.713
1.125
11
11
Profit before tax
39.579
29.456
39.922
29.211
17.647
Tax
8.819
6.654
8.896
6.559
3.968
Net profit
30.760
22.802
31.026
22.652
13.679
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
73.992
77.787
83.183
78.465
54.353
Equity
41.728
32.968
41.166
33.140
23.488
Long-term debt
4.642
6.873
6.719
0
0
Short-term debt
16.696
23.559
21.921
22.074
18.347
Total debt
21.338
30.432
28.640
22.074
30.865
Financial ratios
5-year trend
EBITDA margin (of gross profit)
35,8 %
This company
2021
2025
Equity ratio
56,4 %
This company
38,2 %
Market median
This company
Market median
48% above market
2021
2025
Return on equity
73,7 %
This company
18,4 %
Market median
This company
Market median
301% above market
2021
2025
Net profit margin (of gross profit)
28,5 %
This company
2021
2025
Asset turnover (of gross profit)
1,46×
This company
2021
2025
Debt / equity
0,77×
This company
0,62×
Market median
This company
Market median
24% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on Coloplast Danmark A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
